InspireMD, Inc. (NSPR) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 6 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for NSPR is $5.50, representing a +307.4% upside from the current price of $1.35. Price targets range from a low of $5.00 to a high of $6.00.
